Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

RAPH — Raphael Pharmaceutical Inc. Dilution Risk Tracker

Track RAPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RAPH — Get alerts when the score changes →

As of October 13, 2026, Raphael Pharmaceutical Inc. (RAPH) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Raphael Pharmaceutical Inc. has a market capitalization of $28.25M, 20.18M shares outstanding. Stored dilution-related fields include 920.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 43%
💰 Capital Raise model 55%
• Critical: only 0.3 months cash remaining
🔄 Reverse Split model est. 45%
• 50-day avg $1.40 approaching $1 threshold
• Only 0 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track RAPH — Get forecast alerts →

Market Data

Market Cap$28.25M
Shares Outstanding20.18M
Float11.52M
Cash$20.0K
Debt$41.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding20.18MVerified float table or market cache
Public Float11.52MVerified float table or market cache
Market Cap$28.25MMarket data cache
Cash Runway0.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants920.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2026-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RAPH Dilution Snapshot

Raphael Pharmaceutical Inc. (RAPH) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RAPH's DilutionScore has held steady at 65/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202665/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RAPH shares outstanding have increased 2.8% from 19.63M (Apr 2026) to 20.18M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 09, 202620.18M11.52M▼ 2.95%
Apr 03, 202619.63M11.87M▲ 2.80%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RAPH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RAPH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RAPH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations